Stephen Mason

Track

Insider profile

Currently holds a position at Cardinal Health Inc

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 29% 68% 82%
Transactions
9 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Executive Officer-Medical Segment Cardinal Health Inc Aug. 16, 2019 -
Stephen Mason's trades of Cardinal Health Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
210.63
Quantity 21,753 +44.3%
Value US$3,254,571
Transaction date
Sale
Price
272.62
Quantity 79,250 +19.7%
Value US$3,234,763
Transaction date
Sale
Price
101.78
Quantity 362 -25.4%
Value US$2,423,666
Transaction date
Sale
Price
234.59
Quantity 3,100 -5.8%
Value US$727,229
Transaction date
Proposed sale
Price
236.40
Quantity 35,000
Value US$8,274,153
Transaction date
Proposed sale
Price
148.81
Quantity 41,575
Value US$6,186,923
Transaction date
Sale
Price
149.39
Quantity 4,167 -13.8%
Value US$622,508
Transaction date
Sale
Price
148.83
Quantity 34,411 -53.2%
Value US$5,121,389
Transaction date
Sale
Price
147.87
Quantity 2,997 -4.4%
Value US$443,166
Transaction date
Proposed sale
Price
109.22
Quantity 46,998
Value US$5,132,896
Transaction date
Sale
Price
109.21
Quantity 46,598 -53.2%
Value US$5,088,968
Transaction date
Proposed sale
Price
87.33
Quantity 37,500
Value US$3,274,703
Transaction date
Proposed sale
Price
87.33
Quantity 37,500
Value US$3,274,703
Transaction date
Sale
Price
88.42
Quantity 7,977 -17.6%
Value US$705,326
Transaction date
Sale
Price
87.40
Quantity 18,528 -29.0%
Value US$1,619,347
Transaction date
Sale
Price
86.40
Quantity 10,995 -14.7%
Value US$949,968
Transaction date
Sale
Price
80.87
Quantity 61,216 -55.5%
Value US$4,950,538
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-20 2026-08-18
S Sale
21,753 +44.3%
210.63
US$3,254,571 		21,753 +44.3% 210.63 US$3,254,571
2026-08-20 2026-08-18
S Sale
79,250 +19.7%
272.62
US$3,234,763 		79,250 +19.7% 272.62 US$3,234,763
2026-08-20 2026-08-18
S Sale
362 -25.4%
101.78
US$2,423,666 		362 -25.4% 101.78 US$2,423,666
2026-08-20 2026-08-18
S Sale
3,100 -5.8%
234.59
US$727,229 		3,100 -5.8% 234.59 US$727,229
2026-08-18 2026-08-18
PrS Proposed sale
35,000
236.40
US$8,274,153 		35,000 236.40 US$8,274,153
2025-08-19 2025-08-19
PrS Proposed sale
41,575
148.81
US$6,186,923 		41,575 148.81 US$6,186,923
2025-08-19 2025-08-19
S Sale
4,167 -13.8%
149.39
US$622,508 		4,167 -13.8% 149.39 US$622,508
2025-08-19 2025-08-19
S Sale
34,411 -53.2%
148.83
US$5,121,389 		34,411 -53.2% 148.83 US$5,121,389
2025-08-19 2025-08-19
S Sale
2,997 -4.4%
147.87
US$443,166 		2,997 -4.4% 147.87 US$443,166
2024-08-19 2024-08-19
PrS Proposed sale
46,998
109.22
US$5,132,896 		46,998 109.22 US$5,132,896
2024-08-19 2024-08-19
S Sale
400 -1.0%
109.70
US$43,880 		400 -1.0% 109.70 US$43,880
2024-08-19 2024-08-19
S Sale
46,598 -53.2%
109.21
US$5,088,968 		46,598 -53.2% 109.21 US$5,088,968
2023-08-17 2023-08-17
PrS Proposed sale
37,500
87.33
US$3,274,703 		37,500 87.33 US$3,274,703
2023-08-17 2023-08-17
PrS Proposed sale
37,500
87.33
US$3,274,703 		37,500 87.33 US$3,274,703
2023-08-17 2023-08-17
S Sale
7,977 -17.6%
88.42
US$705,326 		7,977 -17.6% 88.42 US$705,326
2023-08-17 2023-08-17
S Sale
18,528 -29.0%
87.40
US$1,619,347 		18,528 -29.0% 87.40 US$1,619,347
2023-08-17 2023-08-17
S Sale
10,995 -14.7%
86.40
US$949,968 		10,995 -14.7% 86.40 US$949,968
2022-11-09 2022-11-07
S Sale
61,216 -55.5%
80.87
US$4,950,538 		61,216 -55.5% 80.87 US$4,950,538